“…Several reports have shown that both β-caryophyllene oxide and β-caryophyllene possess significant anti-cancer properties, inhibit the growth and proliferation of numerous cancer cell lines [ 24 , 25 , 26 , 27 , 28 ], and are able to enhance the antiproliferative effect of classical anticancer agents, such as 5-fluorouracil, oxaliplatin, paclitaxel, and doxorubicin [ 29 , 30 , 31 , 32 ]. In addition, both of these compounds were found to exhibit anti-inflammatory [ 33 , 34 ], analgesic [ 26 , 35 ], antifungal [ 36 , 37 ], and antibacterial activities [ 28 , 38 , 39 ].…”